Eric Jankowski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eric Jankowski has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Gunter Wolf
Klinik für Innere Medizin III (Nephrologie), Universitätsklinikum Jena, Jena, Deutschland
2 shared publications- Gunter Wolf
Department of Internal Medicine III, University Hospital Jena, Am Klinikum 1, 07747 Jena, Germany
2 shared publications - Ivonne Loeffler
Department of Internal Medicine III, Jena University Hospital, 07747 Jena, Germany
2 shared publications Martin Busch
Klinik für Innere Medizin III (Nephrologie), Universitätsklinikum Jena, Jena, Deutschland
2 shared publications- Nadja Ziller
Department of Internal Medicine III, Jena University Hospital, 07747 Jena, Germany
2 shared publications - Alexander Berndt
Section Pathology of the Institute of Forensic Medicine, Jena University Hospital, Friedrich Schiller University Jena, Am Klinikum 1, 07747 Jena, Germany
1 shared publication
Latest Publications
- Open Access
- 8 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (18) , 7990
MORG1 Haploinsufficiency Is Associated with Stage- and Sex-Dependent Renoprotection and Signalling Alterations in Diabetic Kidney Disease
Type 2 diabetes mellitus (T2DM) is a major age-associated metabolic disease, and aging substantially contributes to the increasing burden and progression of chronic complications, including diabetic kidney disease (DKD). However, the molecular mechanisms underlying changes in renal susceptibility during disease progression remain incompletely understood. We hypothesized that the scaffold protein mitogen-activated protein kinase organizer 1 (MORG1/WDR83) contributes to stage-dependent differences in DKD and that these effects may vary according to biological sex. Heterozygous Morg1 deletion was introduced into the diabetic C57BLKS/J db/db mouse model, and male and female mice were analysed at early and later disease stages alongside non-diabetic controls. Renal fibrosis, albuminuria, HIF-1α expression, mTORC1 and ERK1/2 activity, and renal cortical gene expression were assessed. Morg1 haploinsufficiency was associated with reduced renal fibrosis and albuminuria during early diabetes, whereas these protective effects were less evident in later-stage diabetic animals. HIF-1α expression decreased during progression in most groups but was relatively preserved in later-stage female Morg1 heterozygotes, whereas mTORC1 and ERK1/2 signalling was altered in a genotype- and stage-dependent manner. These findings identify MORG1 as a context-dependent modifier of DKD whose renoprotective effects change across disease progression, linking MORG1-associated signalling to the evolving renal phenotype of an age-associated metabolic disease.
- 8 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (18) , 7990
Open AccessMORG1 Haploinsufficiency Is Associated with Stage- and Sex-Dependent Renoprotection and Signalling Alterations in Diabetic Kidney Disease
Type 2 diabetes mellitus (T2DM) is a major age-associated metabolic disease, and aging substantially contributes to the increasing burden and progression of chronic complications, including diabetic kidney disease (DKD). However, the molecular mechanisms underlying changes in renal susceptibility during disease progression remain incompletely understood. We hypothesized that the scaffold protein mitogen-activated protein kinase organizer 1 (MORG1/WDR83) contributes to stage-dependent differences in DKD and that these effects may vary according to biological sex. Heterozygous Morg1 deletion was introduced into the diabetic C57BLKS/J db/db mouse model, and male and female mice were analysed at early and later disease stages alongside non-diabetic controls. Renal fibrosis, albuminuria, HIF-1α expression, mTORC1 and ERK1/2 activity, and renal cortical gene expression were assessed. Morg1 haploinsufficiency was associated with reduced renal fibrosis and albuminuria during early diabetes, whereas these protective effects were less evident in later-stage diabetic animals. HIF-1α expression decreased during progression in most groups but was relatively preserved in later-stage female Morg1 heterozygotes, whereas mTORC1 and ERK1/2 signalling was altered in a genotype- and stage-dependent manner. These findings identify MORG1 as a context-dependent modifier of DKD whose renoprotective effects change across disease progression, linking MORG1-associated signalling to the evolving renal phenotype of an age-associated metabolic disease.
- Open Access
- 24 March 2026
- Published by Springer Nature in BMC Nephrology
- Vol. 27 (1)
Acute renal failure after dietary change – a case report
Background: The disease entity oxalate nephropathy (ON) is an uncommon but devastating cause of chronic kidney disease associated with the deposition of calcium oxalate crystals in the kidney tubules. The prognosis of ON is poor and targeted therapy is lacking. Case presentation: Here, we report the case of a previously kidney-healthy 59-year-old White female presenting with acute renal failure (ARF) with enlarged kidneys after the consumption of one meal of freshly harvested Swiss chard as part of a longer-term vegetarian dietary change. Kidney biopsy indicated acute tubular damage with intratubular obstruction by oxalate crystal deposition and no evidence of chronic kidney damage or other relevant pathologies. Under conservative therapy and a low-oxalate diet, kidney function improved and the kidneys sonomorphologically returned to a normal size 4 weeks later. After continuing a low-oxalate diet for one year, a return to baseline eGFR was observed, which highlights the importance of nutritional intervention in such cases. Conclusion: This case illustrates the importance of dietary patterns even in cases of an acute kidney failure. It raises relevant research questions, particularly regarding the threshold amount of oxalate crystal deposition in renal tissue that predicts clinically significant oxalate nephropathy.
- 24 March 2026
- Published by Springer Nature in BMC Nephrology
- Vol. 27 (1)
Open AccessAcute renal failure after dietary change – a case report
Background: The disease entity oxalate nephropathy (ON) is an uncommon but devastating cause of chronic kidney disease associated with the deposition of calcium oxalate crystals in the kidney tubules. The prognosis of ON is poor and targeted therapy is lacking. Case presentation: Here, we report the case of a previously kidney-healthy 59-year-old White female presenting with acute renal failure (ARF) with enlarged kidneys after the consumption of one meal of freshly harvested Swiss chard as part of a longer-term vegetarian dietary change. Kidney biopsy indicated acute tubular damage with intratubular obstruction by oxalate crystal deposition and no evidence of chronic kidney damage or other relevant pathologies. Under conservative therapy and a low-oxalate diet, kidney function improved and the kidneys sonomorphologically returned to a normal size 4 weeks later. After continuing a low-oxalate diet for one year, a return to baseline eGFR was observed, which highlights the importance of nutritional intervention in such cases. Conclusion: This case illustrates the importance of dietary patterns even in cases of an acute kidney failure. It raises relevant research questions, particularly regarding the threshold amount of oxalate crystal deposition in renal tissue that predicts clinically significant oxalate nephropathy.
- 30 January 2025
- Published by Springer Nature in Die Nephrologie
- Vol. 20 (3) , 134-149
Pathophysiologie der alternden Niere und ihre klinische Bedeutung für ältere Patienten
- 30 January 2025
- Published by Springer Nature in Die Nephrologie
- Vol. 20 (3) , 134-149
Pathophysiologie der alternden Niere und ihre klinische Bedeutung für ältere Patienten
- Open Access
- 26 September 2024
- Published by Springer Nature in Die Nephrologie
- Vol. 21 (1) , 43-47
Persistierendes Nierenversagen unter Therapie einer Leichtkettennephropathie im Transplantat
- 26 September 2024
- Published by Springer Nature in Die Nephrologie
- Vol. 21 (1) , 43-47
Open AccessPersistierendes Nierenversagen unter Therapie einer Leichtkettennephropathie im Transplantat
- Open Access
- 23 December 2021
- Published by MDPI AG in Biomedicines
- Vol. 10 (1) , 30
MORG1—A Negative Modulator of Renal Lipid Metabolism in Murine Diabetes
Renal fatty acid (FA) metabolism is severely altered in type 1 and 2 diabetes mellitus (T1DM and T2DM). Increasing evidence suggests that altered lipid metabolism is linked to tubulointerstitial fibrosis (TIF). Our previous work has demonstrated that mice with reduced MORG1 expression, a scaffold protein in HIF and ERK signaling, are protected against TIF in the db/db mouse model. Renal TGF-ß1 expression and EMT-like changes were reduced in mice with single-allele deficiency of MORG1. Given the well-known role of HIF and ERK signaling in metabolic regulation, here we examined whether protection was also associated with a restoration of lipid metabolism. Despite similar features of TIF in T1DM and T2DM, diabetes-associated changes in renal lipid metabolism differ between both diseases. We found that de novo synthesis of FA/cholesterol and β-oxidation were more strongly disrupted in T1DM, whereas pathological fat uptake into tubular cells mediates lipotoxicity in T2DM. Thus, diminished MORG1 expression exerts renoprotection in the diabetic nephropathy by modulating important factors of TIF and lipid dysregulation to a variable extent in T1DM and T2DM. Prospectively, targeting MORG1 appears to be a promising strategy to reduce lipid metabolic alterations in diabetic nephropathy.
- 23 December 2021
- Published by MDPI AG in Biomedicines
- Vol. 10 (1) , 30
Open AccessMORG1—A Negative Modulator of Renal Lipid Metabolism in Murine Diabetes
Renal fatty acid (FA) metabolism is severely altered in type 1 and 2 diabetes mellitus (T1DM and T2DM). Increasing evidence suggests that altered lipid metabolism is linked to tubulointerstitial fibrosis (TIF). Our previous work has demonstrated that mice with reduced MORG1 expression, a scaffold protein in HIF and ERK signaling, are protected against TIF in the db/db mouse model. Renal TGF-ß1 expression and EMT-like changes were reduced in mice with single-allele deficiency of MORG1. Given the well-known role of HIF and ERK signaling in metabolic regulation, here we examined whether protection was also associated with a restoration of lipid metabolism. Despite similar features of TIF in T1DM and T2DM, diabetes-associated changes in renal lipid metabolism differ between both diseases. We found that de novo synthesis of FA/cholesterol and β-oxidation were more strongly disrupted in T1DM, whereas pathological fat uptake into tubular cells mediates lipotoxicity in T2DM. Thus, diminished MORG1 expression exerts renoprotection in the diabetic nephropathy by modulating important factors of TIF and lipid dysregulation to a variable extent in T1DM and T2DM. Prospectively, targeting MORG1 appears to be a promising strategy to reduce lipid metabolic alterations in diabetic nephropathy.